Selected Financings
The Company has completed the following financings over the last three completed financial years:
In October 2016, the Company completed a financing in the form of a $750,000 convertible debenture issued by the Company to TY & Sons (the “Debenture”). The Debenture had a term of 24 months, was convertible at a price of $0.25 per Share and $0.50 per Share thereafter, bore interest at a rate of 5% per annum and was subject to a forced conversion provision under certain circumstances.
On January 13, 2017, the Company settled its obligations under the Debenture through the repayment of $720,000 and conversion of the balance of $30,000 into 120,000 Shares.
On January 13, 2017 the Company closed a private placement comprising 20,000,600 Shares issued at a price of $0.25 per Share for gross proceeds of $5,000,150.
On June 22, 2017 the Company closed a private placement comprising 9,894,785 Shares issued at a price of $0.75 per Share for gross proceeds of $7,421,089. The Company paid finder’s fees of $74,841 in cash and issued 590,687 Shares with a fair value of $443,015.
On February 16, 2018, the Company closed a brokered private placement and issued 10,312,821 units of the Company (each, a “ Unit”) at a price of $2.10 per Unit, for gross proceeds of $21,656,924 (the “February 2018 Private Placement”). Each Unit consists of one Share and one-half of one Share purchase warrant (each whole warrant, a “Unit Warrant”. Each Unit Warrant is exercisable to acquire one Share at an exercise price of $2.60 for a period of two years. The Company paid finder’s fees of $2,165,692 in cash, issued 309,384 Shares and granted 721,897 compensation options exercisable for one Unit until February 16, 2020 at an exercise price of $2.10.
On March 21, 2019 the Company closed a bought- deal public offering by way of short form prospectus, comprising 11,390,500 Units at a price of $1.00 per Unit for gross proceeds of $11,390,500 (the “March 2019 Public Offering”). Each Unit consists of one Share and one-half of one Unit Warrant. Each Unit Warrant is exercisable to acquire one Share at an exercise price of $1.30 per share, subject to adjustment in certain events, until March 21, 2022.
On April 15, 2019, the Company closed a private placement comprising 426,000 Units at a price of $1.00 per Unit for gross proceeds of $426,000. Each Unit consists of one Share and one-half of one Unit Warrant. Each Unit Warrant is exercisable to acquire one Share at an exercise price of $1.30 per share, subject to adjustment in certain events, for a period of three years.
On October 30, 2019 the Company entered into a $5,000,000 loan (the “Loan”) and guarantee agreement with LANXESS. US$3.75 million was advanced to the Company, based on an agreed exchange rate, and will be used in the ongoing development of the Demonstration Plant in southern Arkansas, for the demonstration of the Company’s proprietary process for the extraction of lithium from brine solutions.
The principal amount of the Loan will be convertible at the option of LANXESS at a rate such that for each $0.80 of principal converted, the Lender will receive one Common Share and one-half of a Warrant with an exercise price of $1.20 per Common Share and a term of three years. Assuming full conversion of the Loan principal, LANXESS would receive 6,251,250 Common Shares and 3,125,625 Warrants. All securities issued upon conversion of the Loan will be subject to four-month-and-one-day statutory hold period from the date the Loan was advanced.
11